158 related articles for article (PubMed ID: 2751268)
21. CD34+ progenitor cells in idiopathic (primary) myelofibrosis: a comparative quantification between spleen and bone marrow tissue.
Thiele J; Kvasnicka HM; Czieslick C
Ann Hematol; 2002 Feb; 81(2):86-9. PubMed ID: 11907788
[TBL] [Abstract][Full Text] [Related]
22. Agnogenic myelofibrosis in children--a case report and review of the literature.
Hamazaki M; Mugishima H
Acta Pathol Jpn; 1981 Jan; 31(1):143-52. PubMed ID: 7234418
[TBL] [Abstract][Full Text] [Related]
23. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
[TBL] [Abstract][Full Text] [Related]
24. Progressive myelofibrosis in agnogenic myeloid metaplasia.
Lohmann TP; Beckman EN
Arch Pathol Lab Med; 1983 Nov; 107(11):593-4. PubMed ID: 6688716
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune haemolytic anaemia as the presenting manifestation of agnogenic myeloid metaplasia.
Mohite U; Pathare A; al Kindi S; Hiwase D; Vadakkepat N; Knox-Macaulay H
Haematologia (Budap); 2002; 32(4):495-9. PubMed ID: 12803124
[TBL] [Abstract][Full Text] [Related]
26. Follow-up study on bone marrow reticulin fibrosis in AML.
Thiele J; Grashof K; Fisher R
Anal Cell Pathol; 1991 Jul; 3(4):225-31. PubMed ID: 1883746
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
[TBL] [Abstract][Full Text] [Related]
28. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
29. [Clinical features and prognostic factors in primary myelofibrosis patients under 45 years old].
Lu L; Xiao ZJ; Chen HS; Lin H; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):281-4. PubMed ID: 15949290
[TBL] [Abstract][Full Text] [Related]
30. [Study of 161 chronic idiopathic myelofibrosis patients for clinicopathological staging].
Liu AN; Chen HS; Liu EB; Fang LH; Yang QY; Qian LS
Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):178-82. PubMed ID: 16792920
[TBL] [Abstract][Full Text] [Related]
31. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
32. Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.
Tefferi A; Dingli D; Li CY; Dewald GW
Cancer; 2005 Oct; 104(8):1656-60. PubMed ID: 16104040
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
Panteli K; Zagorianakou N; Bai M; Katsaraki A; Agnantis NJ; Bourantas K
Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
[TBL] [Abstract][Full Text] [Related]
34. [Quantitative study of the medullar fibrosis in 84 cases of idiopathic myeloid splenomegaly (author's transl)].
Dumont J; d'Athis P; Atken N; Binet JL; Ripault J; Worhauer W; Bernard J
Pathol Biol (Paris); 1979 Apr; 27(4):221-6. PubMed ID: 379761
[TBL] [Abstract][Full Text] [Related]
35. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
36. Prognostic parameters in myeloid metaplasia: agnogenic versus postpolycythemic.
Meytes D; Katz D; Ramot B
Isr J Med Sci; 1976 Jun; 12(6):534-42. PubMed ID: 955869
[TBL] [Abstract][Full Text] [Related]
37. Acute myelofibrosis.
Das S; Prabhakar BR
Indian J Pathol Microbiol; 1997 Oct; 40(4):527-30. PubMed ID: 9444866
[TBL] [Abstract][Full Text] [Related]
38. Prognostic features at diagnosis of chronic myeloid leukaemia with special emphasis on histological parameters.
Thiele J; Thienel C; Zankovich R; Fischer R
Med Oncol Tumor Pharmacother; 1988; 5(1):49-60. PubMed ID: 3163405
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow biopsy in multiple myeloma: a clinical pathological study.
Aghai E; Avni G; Lurie M; Quitt M; Hornstein L; Froom P
Isr J Med Sci; 1988 Jun; 24(6):298-301. PubMed ID: 3403226
[TBL] [Abstract][Full Text] [Related]
40. [Bone marrow fibrosis in malignant hemopathies and cancers. Histological study of 2 786 biopsies (author's transl)].
Duhamel G; Stachowiak J
Sem Hop; 1981 Jan 18-25; 57(3-4):111-6. PubMed ID: 6261348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
